Successful delayed secondary open conversion after endovascular repair using partial explantation technique: a single-center experience.
Academic Article
Overview
abstract
BACKGROUND: Endovascular aneurysm repair (EVAR) reduces the morbidity and mortality associated with abdominal aortic aneurysm repair, but in some patients endoleak or aneurysm expansion may necessitate secondary open conversion (SOC). We reviewed the outcomes after delayed SOC following EVAR in consecutive patients at a single center. METHODS: We retrospectively reviewed all patients undergoing EVAR to identify a cohort undergoing delayed SOC in a single center between 1998 and 2008. We analyzed delayed SOC patients for operative indications, technique, and early outcomes. We made specific comment on the surgical techniques used, with respect to partial or total endograft explantation. RESULTS: Delayed SOC was carried out in 10/285 (3.5%) consecutive patients implanted with the Zenith endograft; during this period, two further patients had SOC after initial EVAR in another center. Graft types were Zenith (n = 10), Talent (n = 1), and AneuRx (n = 1). Indications for open conversion were infected graft (n = 3), sac expansion (n = 3), type 1 endoleak (n = 2), type 2 endoleak (n = 2), juxtarenal aneurysm (n = 1), and rupture (n = 1). Explantation techniques were partial explantation with in situ replacement (n = 7), full explantation with axillobifemoral bypass (n = 3), in situ replacement (n = 1), and suturing (n = 1)Complete stent explantation was required in 4 patients with axillo-bifemoral bypass in three of them. 7 patients had partial stent explantation and one patient stent was left insitu. Postoperative morbidities included myocardial infarction (n = 1), renal dialysis (n = 1), and chest infection (n = 3). No 30-day mortality was noted, and all patients were discharged from hospital and remain well with median follow-up of 5 months (interquartile range 1.7-26.7). CONCLUSION: SOC after EVAR is feasible in selected patients with low morbidity and mortality. Partial explantation with in situ replacement, in the absence of sepsis, may be the preferred revascularization option but may require long-term follow-up.
